aluates Reports

$ 0.0

Automative

Global Intelligent Drug R-D Services Market Research Report 2024

Published Date: July 2024

Report Code: QYRE-Auto-28C13766

Global Intelligent Drug R D Services Market Research Report 2023

BUY CHAPTERS

Global Intelligent Drug R-D Services Market Research Report 2024

Code: QYRE-Auto-28C13766

Report

July 2024

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Intelligent Drug R-D Services Market Size

The global Intelligent Drug R-D Services market was valued at US$ 1200 million in 2023 and is anticipated to reach US$ 6558.6 million by 2030, witnessing a CAGR of 28.6% during the forecast period 2024-2030.

Intelligent Drug R-D Services Market

Leading biopharmaceutical companies believe in AI due to growing awareness in the pharmaceutical sector and rising investment in drug development. AI works with the latest advanced biology and chemistry processes to develop state-of-the-art algorithms; it has the potential to move drug screening from the bench to a virtual lab without the need for extensive experimental input and manpower.Most biopharmaceutical companies have started internal programs or are collaborating to develop AI platforms for increasing the research power of immuno-oncology drugs, metabolic-disease therapies, cancer treatments, and many other therapeutic targets.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Intelligent Drug R-D Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intelligent Drug R-D Services.

Report Scope

The Intelligent Drug R-D Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intelligent Drug R-D Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intelligent Drug R-D Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Intelligent Drug R-D Services Market Report

Report Metric	Details
Report Name	Intelligent Drug R-D Services Market
Accounted market size in 2023	US$ 1200 million
Forecasted market size in 2030	US$ 6558.6 million
CAGR	28.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Cloud Based On-Premise
Segment by Application	Drug Discovery Research Drug Development Research Clinical Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BenevolentAI, Exscientia, IBM, Alphabet, Berg Health, Atomwise, Insitro, Cyclica, NVIDIA, Insilico Medicine, AstraZeneca, CAPGEMINI ENGINEERING, Hafnium Labs ApS, XtalPi Inc, Schrödinger, Charles River Laboratories, IQVIA Inc, Healx, Innoplexus, EVAXION BIOTECH A/S, Icometrix
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intelligent Drug R-D Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Intelligent Drug R-D Services Market growing?

Ans: The Intelligent Drug R-D Services Market witnessing a CAGR of 28.6% during the forecast period 2024-2030.

What is the Intelligent Drug R-D Services Market size in 2030?

Ans: The Intelligent Drug R-D Services Market size in 2030 will be US$ 6558.6 million.

Who are the main players in the Intelligent Drug R-D Services Market report?

Ans: The main players in the Intelligent Drug R-D Services Market are BenevolentAI, Exscientia, IBM, Alphabet, Berg Health, Atomwise, Insitro, Cyclica, NVIDIA, Insilico Medicine, AstraZeneca, CAPGEMINI ENGINEERING, Hafnium Labs ApS, XtalPi Inc, Schrödinger, Charles River Laboratories, IQVIA Inc, Healx, Innoplexus, EVAXION BIOTECH A/S, Icometrix

What are the Application segmentation covered in the Intelligent Drug R-D Services Market report?

Ans: The Applications covered in the Intelligent Drug R-D Services Market report are Drug Discovery Research, Drug Development Research, Clinical Research

What are the Type segmentation covered in the Intelligent Drug R-D Services Market report?

Ans: The Types covered in the Intelligent Drug R-D Services Market report are Cloud Based, On-Premise

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Intelligent Drug R-D Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Cloud Based

1.2.3 On-Premise

1.3 Market by Application

1.3.1 Global Intelligent Drug R-D Services Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Drug Discovery Research

1.3.3 Drug Development Research

1.3.4 Clinical Research

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Intelligent Drug R-D Services Market Perspective (2019-2030)

2.2 Intelligent Drug R-D Services Growth Trends by Region

2.2.1 Global Intelligent Drug R-D Services Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Intelligent Drug R-D Services Historic Market Size by Region (2019-2024)

2.2.3 Intelligent Drug R-D Services Forecasted Market Size by Region (2025-2030)

2.3 Intelligent Drug R-D Services Market Dynamics

2.3.1 Intelligent Drug R-D Services Industry Trends

2.3.2 Intelligent Drug R-D Services Market Drivers

2.3.3 Intelligent Drug R-D Services Market Challenges

2.3.4 Intelligent Drug R-D Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Intelligent Drug R-D Services Players by Revenue

3.1.1 Global Top Intelligent Drug R-D Services Players by Revenue (2019-2024)

3.1.2 Global Intelligent Drug R-D Services Revenue Market Share by Players (2019-2024)

3.2 Global Intelligent Drug R-D Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Intelligent Drug R-D Services Revenue

3.4 Global Intelligent Drug R-D Services Market Concentration Ratio

3.4.1 Global Intelligent Drug R-D Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Intelligent Drug R-D Services Revenue in 2023

3.5 Intelligent Drug R-D Services Key Players Head office and Area Served

3.6 Key Players Intelligent Drug R-D Services Product Solution and Service

3.7 Date of Enter into Intelligent Drug R-D Services Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Intelligent Drug R-D Services Breakdown Data by Type

4.1 Global Intelligent Drug R-D Services Historic Market Size by Type (2019-2024)

4.2 Global Intelligent Drug R-D Services Forecasted Market Size by Type (2025-2030)

5 Intelligent Drug R-D Services Breakdown Data by Application

5.1 Global Intelligent Drug R-D Services Historic Market Size by Application (2019-2024)

5.2 Global Intelligent Drug R-D Services Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Intelligent Drug R-D Services Market Size (2019-2030)

6.2 North America Intelligent Drug R-D Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Intelligent Drug R-D Services Market Size by Country (2019-2024)

6.4 North America Intelligent Drug R-D Services Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Intelligent Drug R-D Services Market Size (2019-2030)

7.2 Europe Intelligent Drug R-D Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Intelligent Drug R-D Services Market Size by Country (2019-2024)

7.4 Europe Intelligent Drug R-D Services Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Intelligent Drug R-D Services Market Size (2019-2030)

8.2 Asia-Pacific Intelligent Drug R-D Services Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Intelligent Drug R-D Services Market Size by Region (2019-2024)

8.4 Asia-Pacific Intelligent Drug R-D Services Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Intelligent Drug R-D Services Market Size (2019-2030)

9.2 Latin America Intelligent Drug R-D Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Intelligent Drug R-D Services Market Size by Country (2019-2024)

9.4 Latin America Intelligent Drug R-D Services Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Intelligent Drug R-D Services Market Size (2019-2030)

10.2 Middle East & Africa Intelligent Drug R-D Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Intelligent Drug R-D Services Market Size by Country (2019-2024)

10.4 Middle East & Africa Intelligent Drug R-D Services Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BenevolentAI

11.1.1 BenevolentAI Company Detail

11.1.2 BenevolentAI Business Overview

11.1.3 BenevolentAI Intelligent Drug R-D Services Introduction

11.1.4 BenevolentAI Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.1.5 BenevolentAI Recent Development

11.2 Exscientia

11.2.1 Exscientia Company Detail

11.2.2 Exscientia Business Overview

11.2.3 Exscientia Intelligent Drug R-D Services Introduction

11.2.4 Exscientia Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.2.5 Exscientia Recent Development

11.3 IBM

11.3.1 IBM Company Detail

11.3.2 IBM Business Overview

11.3.3 IBM Intelligent Drug R-D Services Introduction

11.3.4 IBM Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.3.5 IBM Recent Development

11.4 Alphabet

11.4.1 Alphabet Company Detail

11.4.2 Alphabet Business Overview

11.4.3 Alphabet Intelligent Drug R-D Services Introduction

11.4.4 Alphabet Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.4.5 Alphabet Recent Development

11.5 Berg Health

11.5.1 Berg Health Company Detail

11.5.2 Berg Health Business Overview

11.5.3 Berg Health Intelligent Drug R-D Services Introduction

11.5.4 Berg Health Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.5.5 Berg Health Recent Development

11.6 Atomwise

11.6.1 Atomwise Company Detail

11.6.2 Atomwise Business Overview

11.6.3 Atomwise Intelligent Drug R-D Services Introduction

11.6.4 Atomwise Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.6.5 Atomwise Recent Development

11.7 Insitro

11.7.1 Insitro Company Detail

11.7.2 Insitro Business Overview

11.7.3 Insitro Intelligent Drug R-D Services Introduction

11.7.4 Insitro Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.7.5 Insitro Recent Development

11.8 Cyclica

11.8.1 Cyclica Company Detail

11.8.2 Cyclica Business Overview

11.8.3 Cyclica Intelligent Drug R-D Services Introduction

11.8.4 Cyclica Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.8.5 Cyclica Recent Development

11.9 NVIDIA

11.9.1 NVIDIA Company Detail

11.9.2 NVIDIA Business Overview

11.9.3 NVIDIA Intelligent Drug R-D Services Introduction

11.9.4 NVIDIA Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.9.5 NVIDIA Recent Development

11.10 Insilico Medicine

11.10.1 Insilico Medicine Company Detail

11.10.2 Insilico Medicine Business Overview

11.10.3 Insilico Medicine Intelligent Drug R-D Services Introduction

11.10.4 Insilico Medicine Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.10.5 Insilico Medicine Recent Development

11.11 AstraZeneca

11.11.1 AstraZeneca Company Detail

11.11.2 AstraZeneca Business Overview

11.11.3 AstraZeneca Intelligent Drug R-D Services Introduction

11.11.4 AstraZeneca Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.11.5 AstraZeneca Recent Development

11.12 CAPGEMINI ENGINEERING

11.12.1 CAPGEMINI ENGINEERING Company Detail

11.12.2 CAPGEMINI ENGINEERING Business Overview

11.12.3 CAPGEMINI ENGINEERING Intelligent Drug R-D Services Introduction

11.12.4 CAPGEMINI ENGINEERING Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.12.5 CAPGEMINI ENGINEERING Recent Development

11.13 Hafnium Labs ApS

11.13.1 Hafnium Labs ApS Company Detail

11.13.2 Hafnium Labs ApS Business Overview

11.13.3 Hafnium Labs ApS Intelligent Drug R-D Services Introduction

11.13.4 Hafnium Labs ApS Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.13.5 Hafnium Labs ApS Recent Development

11.14 XtalPi Inc

11.14.1 XtalPi Inc Company Detail

11.14.2 XtalPi Inc Business Overview

11.14.3 XtalPi Inc Intelligent Drug R-D Services Introduction

11.14.4 XtalPi Inc Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.14.5 XtalPi Inc Recent Development

11.15 Schrödinger

11.15.1 Schrödinger Company Detail

11.15.2 Schrödinger Business Overview

11.15.3 Schrödinger Intelligent Drug R-D Services Introduction

11.15.4 Schrödinger Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.15.5 Schrödinger Recent Development

11.16 Charles River Laboratories

11.16.1 Charles River Laboratories Company Detail

11.16.2 Charles River Laboratories Business Overview

11.16.3 Charles River Laboratories Intelligent Drug R-D Services Introduction

11.16.4 Charles River Laboratories Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.16.5 Charles River Laboratories Recent Development

11.17 IQVIA Inc

11.17.1 IQVIA Inc Company Detail

11.17.2 IQVIA Inc Business Overview

11.17.3 IQVIA Inc Intelligent Drug R-D Services Introduction

11.17.4 IQVIA Inc Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.17.5 IQVIA Inc Recent Development

11.18 Healx

11.18.1 Healx Company Detail

11.18.2 Healx Business Overview

11.18.3 Healx Intelligent Drug R-D Services Introduction

11.18.4 Healx Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.18.5 Healx Recent Development

11.19 Innoplexus

11.19.1 Innoplexus Company Detail

11.19.2 Innoplexus Business Overview

11.19.3 Innoplexus Intelligent Drug R-D Services Introduction

11.19.4 Innoplexus Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.19.5 Innoplexus Recent Development

11.20 EVAXION BIOTECH A/S

11.20.1 EVAXION BIOTECH A/S Company Detail

11.20.2 EVAXION BIOTECH A/S Business Overview

11.20.3 EVAXION BIOTECH A/S Intelligent Drug R-D Services Introduction

11.20.4 EVAXION BIOTECH A/S Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.20.5 EVAXION BIOTECH A/S Recent Development

11.21 Icometrix

11.21.1 Icometrix Company Detail

11.21.2 Icometrix Business Overview

11.21.3 Icometrix Intelligent Drug R-D Services Introduction

11.21.4 Icometrix Revenue in Intelligent Drug R-D Services Business (2019-2024)

11.21.5 Icometrix Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Intelligent Drug R-D Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Cloud Based

Table 3. Key Players of On-Premise

Table 4. Global Intelligent Drug R-D Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Intelligent Drug R-D Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Intelligent Drug R-D Services Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Intelligent Drug R-D Services Market Share by Region (2019-2024)

Table 8. Global Intelligent Drug R-D Services Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Intelligent Drug R-D Services Market Share by Region (2025-2030)

Table 10. Intelligent Drug R-D Services Market Trends

Table 11. Intelligent Drug R-D Services Market Drivers

Table 12. Intelligent Drug R-D Services Market Challenges

Table 13. Intelligent Drug R-D Services Market Restraints

Table 14. Global Intelligent Drug R-D Services Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Intelligent Drug R-D Services Market Share by Players (2019-2024)

Table 16. Global Top Intelligent Drug R-D Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intelligent Drug R-D Services as of 2023)

Table 17. Ranking of Global Top Intelligent Drug R-D Services Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Intelligent Drug R-D Services Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Intelligent Drug R-D Services Product Solution and Service

Table 21. Date of Enter into Intelligent Drug R-D Services Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Intelligent Drug R-D Services Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Intelligent Drug R-D Services Revenue Market Share by Type (2019-2024)

Table 25. Global Intelligent Drug R-D Services Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Intelligent Drug R-D Services Revenue Market Share by Type (2025-2030)

Table 27. Global Intelligent Drug R-D Services Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Intelligent Drug R-D Services Revenue Market Share by Application (2019-2024)

Table 29. Global Intelligent Drug R-D Services Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Intelligent Drug R-D Services Revenue Market Share by Application (2025-2030)

Table 31. North America Intelligent Drug R-D Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Intelligent Drug R-D Services Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Intelligent Drug R-D Services Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Intelligent Drug R-D Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Intelligent Drug R-D Services Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Intelligent Drug R-D Services Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Intelligent Drug R-D Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Intelligent Drug R-D Services Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Intelligent Drug R-D Services Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Intelligent Drug R-D Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Intelligent Drug R-D Services Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Intelligent Drug R-D Services Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Intelligent Drug R-D Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Intelligent Drug R-D Services Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Intelligent Drug R-D Services Market Size by Country (2025-2030) & (US$ Million)

Table 46. BenevolentAI Company Detail

Table 47. BenevolentAI Business Overview

Table 48. BenevolentAI Intelligent Drug R-D Services Product

Table 49. BenevolentAI Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 50. BenevolentAI Recent Development

Table 51. Exscientia Company Detail

Table 52. Exscientia Business Overview

Table 53. Exscientia Intelligent Drug R-D Services Product

Table 54. Exscientia Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 55. Exscientia Recent Development

Table 56. IBM Company Detail

Table 57. IBM Business Overview

Table 58. IBM Intelligent Drug R-D Services Product

Table 59. IBM Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 60. IBM Recent Development

Table 61. Alphabet Company Detail

Table 62. Alphabet Business Overview

Table 63. Alphabet Intelligent Drug R-D Services Product

Table 64. Alphabet Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 65. Alphabet Recent Development

Table 66. Berg Health Company Detail

Table 67. Berg Health Business Overview

Table 68. Berg Health Intelligent Drug R-D Services Product

Table 69. Berg Health Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 70. Berg Health Recent Development

Table 71. Atomwise Company Detail

Table 72. Atomwise Business Overview

Table 73. Atomwise Intelligent Drug R-D Services Product

Table 74. Atomwise Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 75. Atomwise Recent Development

Table 76. Insitro Company Detail

Table 77. Insitro Business Overview

Table 78. Insitro Intelligent Drug R-D Services Product

Table 79. Insitro Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 80. Insitro Recent Development

Table 81. Cyclica Company Detail

Table 82. Cyclica Business Overview

Table 83. Cyclica Intelligent Drug R-D Services Product

Table 84. Cyclica Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 85. Cyclica Recent Development

Table 86. NVIDIA Company Detail

Table 87. NVIDIA Business Overview

Table 88. NVIDIA Intelligent Drug R-D Services Product

Table 89. NVIDIA Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 90. NVIDIA Recent Development

Table 91. Insilico Medicine Company Detail

Table 92. Insilico Medicine Business Overview

Table 93. Insilico Medicine Intelligent Drug R-D Services Product

Table 94. Insilico Medicine Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 95. Insilico Medicine Recent Development

Table 96. AstraZeneca Company Detail

Table 97. AstraZeneca Business Overview

Table 98. AstraZeneca Intelligent Drug R-D Services Product

Table 99. AstraZeneca Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 100. AstraZeneca Recent Development

Table 101. CAPGEMINI ENGINEERING Company Detail

Table 102. CAPGEMINI ENGINEERING Business Overview

Table 103. CAPGEMINI ENGINEERING Intelligent Drug R-D Services Product

Table 104. CAPGEMINI ENGINEERING Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 105. CAPGEMINI ENGINEERING Recent Development

Table 106. Hafnium Labs ApS Company Detail

Table 107. Hafnium Labs ApS Business Overview

Table 108. Hafnium Labs ApS Intelligent Drug R-D Services Product

Table 109. Hafnium Labs ApS Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 110. Hafnium Labs ApS Recent Development

Table 111. XtalPi Inc Company Detail

Table 112. XtalPi Inc Business Overview

Table 113. XtalPi Inc Intelligent Drug R-D Services Product

Table 114. XtalPi Inc Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 115. XtalPi Inc Recent Development

Table 116. Schrödinger Company Detail

Table 117. Schrödinger Business Overview

Table 118. Schrödinger Intelligent Drug R-D Services Product

Table 119. Schrödinger Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 120. Schrödinger Recent Development

Table 121. Charles River Laboratories Company Detail

Table 122. Charles River Laboratories Business Overview

Table 123. Charles River Laboratories Intelligent Drug R-D Services Product

Table 124. Charles River Laboratories Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 125. Charles River Laboratories Recent Development

Table 126. IQVIA Inc Company Detail

Table 127. IQVIA Inc Business Overview

Table 128. IQVIA Inc Intelligent Drug R-D Services Product

Table 129. IQVIA Inc Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 130. IQVIA Inc Recent Development

Table 131. Healx Company Detail

Table 132. Healx Business Overview

Table 133. Healx Intelligent Drug R-D Services Product

Table 134. Healx Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 135. Healx Recent Development

Table 136. Innoplexus Company Detail

Table 137. Innoplexus Business Overview

Table 138. Innoplexus Intelligent Drug R-D Services Product

Table 139. Innoplexus Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 140. Innoplexus Recent Development

Table 141. EVAXION BIOTECH A/S Company Detail

Table 142. EVAXION BIOTECH A/S Business Overview

Table 143. EVAXION BIOTECH A/S Intelligent Drug R-D Services Product

Table 144. EVAXION BIOTECH A/S Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 145. EVAXION BIOTECH A/S Recent Development

Table 146. Icometrix Company Detail

Table 147. Icometrix Business Overview

Table 148. Icometrix Intelligent Drug R-D Services Product

Table 149. Icometrix Revenue in Intelligent Drug R-D Services Business (2019-2024) & (US$ Million)

Table 150. Icometrix Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Intelligent Drug R-D Services Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Intelligent Drug R-D Services Market Share by Type: 2023 VS 2030

Figure 3. Cloud Based Features

Figure 4. On-Premise Features

Figure 5. Global Intelligent Drug R-D Services Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Intelligent Drug R-D Services Market Share by Application: 2023 VS 2030

Figure 7. Drug Discovery Research Case Studies

Figure 8. Drug Development Research Case Studies

Figure 9. Clinical Research Case Studies

Figure 10. Intelligent Drug R-D Services Report Years Considered

Figure 11. Global Intelligent Drug R-D Services Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Intelligent Drug R-D Services Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Intelligent Drug R-D Services Market Share by Region: 2023 VS 2030

Figure 14. Global Intelligent Drug R-D Services Market Share by Players in 2023

Figure 15. Global Top Intelligent Drug R-D Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intelligent Drug R-D Services as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Intelligent Drug R-D Services Revenue in 2023

Figure 17. North America Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Intelligent Drug R-D Services Market Share by Country (2019-2030)

Figure 19. United States Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Intelligent Drug R-D Services Market Share by Country (2019-2030)

Figure 23. Germany Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Intelligent Drug R-D Services Market Share by Region (2019-2030)

Figure 31. China Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Intelligent Drug R-D Services Market Share by Country (2019-2030)

Figure 39. Mexico Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Intelligent Drug R-D Services Market Share by Country (2019-2030)

Figure 43. Turkey Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Intelligent Drug R-D Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. BenevolentAI Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 46. Exscientia Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 47. IBM Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 48. Alphabet Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 49. Berg Health Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 50. Atomwise Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 51. Insitro Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 52. Cyclica Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 53. NVIDIA Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 54. Insilico Medicine Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 55. AstraZeneca Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 56. CAPGEMINI ENGINEERING Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 57. Hafnium Labs ApS Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 58. XtalPi Inc Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 59. Schrödinger Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 60. Charles River Laboratories Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 61. IQVIA Inc Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 62. Healx Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 63. Innoplexus Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 64. EVAXION BIOTECH A/S Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 65. Icometrix Revenue Growth Rate in Intelligent Drug R-D Services Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-36O13443

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Tumor Marker Detection Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-29Q13199

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Capsule Filling Machines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5E14004

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Gradient PCR Instrument - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-21Q12960

Tue Oct 22 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Intelligent Drug R-D Services Market Research Report 2024

Published Date: July 2024

Report Code: QYRE-Auto-28C13766

Global Intelligent Drug R-D Services Market Research Report 2024

FEATURED COMPANIES

Intelligent Drug R-D Services Market Size

Intelligent Drug R-D Services Market

Report Scope

Scope of Intelligent Drug R-D Services Market Report

Chapter Outline

FAQ for this report

How fast is Intelligent Drug R-D Services Market growing?

What is the Intelligent Drug R-D Services Market size in 2030?

Who are the main players in the Intelligent Drug R-D Services Market report?

What are the Application segmentation covered in the Intelligent Drug R-D Services Market report?

What are the Type segmentation covered in the Intelligent Drug R-D Services Market report?

FEATURED COMPANIES

RELATED REPORTS